These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23127263)

  • 1. Lamotrigine serum concentration in children with epilepsy.
    Heyman E; Lavie R; Lahat E; Braunstein R; Bar-Haim A; Berkovitch M; Gandelman-Marton R
    Pediatr Neurol; 2012 Dec; 47(6):427-30. PubMed ID: 23127263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels.
    Fröscher W; Keller F; Vogt H; Krämer G
    Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine in children with refractory epilepsy.
    Celebi A; Yalnmzoğlu D; Turanli G; Topaloğlu H; Aysun S; Topçu M
    Turk J Pediatr; 2008; 50(5):426-31. PubMed ID: 19102045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.
    Lovrić M; Božina N; Hajnšek S; Kuzman MR; Sporiš D; Lalić Z; Božina T; Granić P
    Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
    Uvebrant P; Bauzienè R
    Neuropediatrics; 1994 Dec; 25(6):284-9. PubMed ID: 7770124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine--a clinical overview.
    Wallace SJ
    Seizure; 1994 Dec; 3 Suppl A():47-51. PubMed ID: 7894852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy.
    Hirsch LJ; Weintraub D; Du Y; Buchsbaum R; Spencer HT; Hager M; Straka T; Bazil CW; Adams DJ; Resor SR; Morrell MJ
    Neurology; 2004 Sep; 63(6):1022-6. PubMed ID: 15452293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual changes in lamotrigine plasma concentrations during pregnancy.
    Petrenaite V; Sabers A; Hansen-Schwartz J
    Epilepsy Res; 2005 Jul; 65(3):185-8. PubMed ID: 16084694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.